Carcinoma, Hepatocellular
"Carcinoma, Hepatocellular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Descriptor ID |
D006528
|
| MeSH Number(s) |
C04.557.470.200.025.255 C04.588.274.623.160 C06.301.623.160 C06.552.697.160
|
| Concept/Terms |
Carcinoma, Hepatocellular- Carcinoma, Hepatocellular
- Carcinomas, Hepatocellular
- Hepatocellular Carcinomas
- Liver Cell Carcinoma, Adult
- Liver Cancer, Adult
- Adult Liver Cancer
- Adult Liver Cancers
- Cancer, Adult Liver
- Cancers, Adult Liver
- Liver Cancers, Adult
- Liver Cell Carcinoma
- Carcinoma, Liver Cell
- Carcinomas, Liver Cell
- Cell Carcinoma, Liver
- Cell Carcinomas, Liver
- Liver Cell Carcinomas
- Hepatocellular Carcinoma
- Hepatoma
- Hepatomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Hepatocellular".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Hepatocellular".
This graph shows the total number of publications written about "Carcinoma, Hepatocellular" by people in this website by year, and whether "Carcinoma, Hepatocellular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 3 | 4 |
| 2001 | 7 | 1 | 8 |
| 2002 | 7 | 4 | 11 |
| 2003 | 4 | 2 | 6 |
| 2004 | 6 | 3 | 9 |
| 2005 | 7 | 0 | 7 |
| 2006 | 4 | 2 | 6 |
| 2007 | 9 | 0 | 9 |
| 2008 | 9 | 5 | 14 |
| 2009 | 11 | 4 | 15 |
| 2010 | 16 | 3 | 19 |
| 2011 | 13 | 3 | 16 |
| 2012 | 9 | 1 | 10 |
| 2013 | 18 | 0 | 18 |
| 2014 | 13 | 2 | 15 |
| 2015 | 17 | 2 | 19 |
| 2016 | 15 | 3 | 18 |
| 2017 | 22 | 3 | 25 |
| 2018 | 25 | 1 | 26 |
| 2019 | 39 | 1 | 40 |
| 2020 | 45 | 0 | 45 |
| 2021 | 39 | 2 | 41 |
| 2022 | 52 | 0 | 52 |
| 2023 | 36 | 1 | 37 |
| 2024 | 30 | 5 | 35 |
| 2025 | 13 | 1 | 14 |
| 2026 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Hepatocellular" by people in Profiles.
-
Validation of longitudinal biomarker screening algorithms for HCC detection in patients with cirrhosis. Hepatol Commun. 2026 Mar 01; 10(3).
-
Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study. Transpl Int. 2025; 38:15298.
-
Evolving burden of metabolic dysfunction-associated steatotic liver disease and its complications in a US nationwide healthcare system. Hepatol Commun. 2026 Jan 01; 10(1).
-
Case of Advanced Hepatocellular Carcinoma Treated With Transarterial Radioembolization and Subsequent Liver Transplantation in a 22-Month-old. J Pediatr Hematol Oncol. 2026 Jan 01; 48(1):e35-e40.
-
Multi-omic analysis of hepatocellular carcinoma reveals aberrant cis-regulatory changes and dysregulated retrotransposons with prognostic potential. Commun Biol. 2025 Dec 13; 8(1):1792.
-
Reverse Lipid Droplet Function for Hepatocellular Carcinoma Immunotherapy. Angew Chem Int Ed Engl. 2026 Jan 22; 65(4):e20609.
-
Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma. Cell Rep. 2025 Nov 25; 44(11):116313.
-
HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort. J Hepatol. 2026 Mar; 84(3):578-586.
-
Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits. Int J Cancer. 2026 Mar 01; 158(5):1193-1203.
-
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications. Curr Oncol. 2025 Sep 13; 32(9).